FEBRUARY, 2012 Gene-Related Patent Applications Posted - Full application


ACTIVE SOLID-STATE DEVICES
Appl Number Title Assignee Date Issued Country
20120037919 NANOPORE ELECTRICAL SENSOR Zhejian University 16-Feb-12 China P. Rep.
CHEMISTRY: ANALYTICAL AND IMMUNOLOGICAL TESTING
Appl Number Title Assignee Date Issued Country
20120028359 PRODUCTION PROCESS OF GENDER-SPECIFIC SERUM AND BIOMARKER USING THE SERUM Choi; In Ho 2-Feb-12 Korea
20120034605 METHOD FOR DETECTION OF COLORECTAL TUMOR A&T CORPORATION 9-Feb-12 Japan
20120045760 Single Nucleotide Polymorphism Within An Intronic P53 Binding Motif of the Prkag2 Gene AGENCY FOR SCIENCE, TECHNOLOGY, AND RESEARCH 23-Feb-12 Singapore
20120028348 MULTIPLE RNA POLYMERASE III PROMOTER EXPRESSION CONSTRUCTS ALNYLAM PHARMACEUTICALS, INC. 2-Feb-12 United States
20120034654 METHOD FOR TRANSFORMING SCHIZOSACCHAROMYCES POMBE, TRANSFORMANT OF SCHIZOSACCHAROMYCES POMBE AND METHOD FOR PRODUCING HETEROLOGOUS PROTEIN ASAHI GLASS COMPANY, LIMITED 9-Feb-12 Japan
20120040400 Novel Permanent Human Cell Line Cevec Pharmaceuticals GMBH 16-Feb-12 Germany
20120034617 ASSAYS FOR BACTERIAL DETECTION AND IDENTIFICATION Cheung; Ambrose Lin-Yau 9-Feb-12 United States
20120034634 MODIFIED LUCIOLA CRUCIATA LUCIFERASE PROTEIN Coleman; Daniel J 9-Feb-12 United States
20120040434 Protein exhibiting activity of pyrethrin biosynthetic enzyme, gene encoding the protein, and vector bearing the gene DAINIHON JOCHUGIKU CO., LTD. 16-Feb-12 Japan
20120040346 Method of Determining Chemotherapy of Metastatic Tumor by Assaying DPD Gene Expression in Primary Tumors Danenberg; Kathleen D 16-Feb-12 United States
20120040433 LIVE, ORAL VACCINE FOR PROTECTION AGAINST SHIGELLA DYSENTERIAE SEROTYPE 1 DEPARTMENT OF HEALTH AND HUMAN SERVICES 16-Feb-12 United States
20120040334 Diagnostic Transcript and Splice Patterns of HPV16 in Different Cervical Lesions DEUTSCHES KREBSFORSCHUNGSZENTRUM 16-Feb-12 Germany
20120028336 Single Recombination System and Methods of Use EMERGENT PRODUCT DEVELOPMENT GERMANY GMBH 2-Feb-12 Germany
20120040451 MOLECULES ABLE TO MODULATE THE EXPRESSION OF AT LEAST A GENE INVOLVED IN DEGRADATIVE PATHWAYS AND USES THEREOF FONDAZIONE TELETHON 16-Feb-12 Italy
20120034609 GENE DETECTION ASSAY FOR IMPROVING THE LIKELIHOOD OF AN EFFECTIVE RESPONSE TO AN EGFR ANTAGONIST CANCER THERAPY Genentech, Inc. 9-Feb-12 United States
20120040426 PRIMARY ALCOHOL PRODUCING ORGANISMS GENOMATICA, INC. 16-Feb-12 United States
20120034604 USE OF BASIC PROLIN-RICH LACRIMAL GENE PRODUCTS, SUCH AS OPIORPHIN, AS A BIOMARKER INSTITUT PASTEUR 9-Feb-12 France
20120040460 Ribonucleic Acid Interference Molecules INTERNATIONAL BUSINESS MACHINES CORPORATION 16-Feb-12 United States
20120028300 Whitefly Ecdysone Receptor Nucleic Acids, Polypeptides, and Uses Thereof Intrexon Corporation 2-Feb-12 United States
20120028257 Modified luciola cruciata luciferase gene and protein Marker Gene Technologies, Inc. 2-Feb-12 United States
20120034653 Trophic Conversion of Obligate Phototrophic Algae Through Metabolic Engineering Martek Biosciences Corporation 9-Feb-12 United States
20120040441 TRANSFORMED STRAINS ORIGINATED FROM MULTIDRUG EFFLUX PROTEIN DEFECTIVE STRAINS AND A METHOD FOR MICROBIAL CONVERSION USING THEM MERCIAN CORPORATION 16-Feb-12 Japan
20120034608 MICRORNA AS A BIOMARKER OF PANCREATIC ISLET BETA-CELL ENGAGEMENT Merck Sharp & Dohme Corp. 9-Feb-12 United States
20120045835 PORTABLE DEVICE BASED ON IMMOBILIZED CELLS FOR THE DETECTION OF ANALYTES Michelini; Elisa 23-Feb-12 Italy
20120028317 HYDROXYNITRILE LYASE Mitsubishi Rayon Co., Ltd. 2-Feb-12 Japan
20120040417 HYDROXYNITRILE LYASE Mitsubishi Rayon Co., Ltd. 16-Feb-12 Japan
20120028309 Method for producing indole derivative National Chiao Tung University 2-Feb-12 Taiwan
20120028356 TRANSFECTION WITH MICRO EXPLOSION ENACTED BY COATED DRY ICE PARTICLES NATIONAL YANG MING UNIVERSITY 2-Feb-12 Taiwan
20120034652 Method for the Targeted Integration of Multiple Copies of a Gene of Interest in a Yarrowia Strain Nicaud; Jean-Marc 9-Feb-12 France
20120034650 Nucleic acid molecule of a biosynthetic cluster encoding non ribosomal peptide synthases and uses thereof NOVARTIS AG 9-Feb-12 Switzerland
20120034613 Apparatus and Method for Testing Relationships Between Gene Expression and Physical Appearance of Skin NSE Products, Inc. 9-Feb-12 United States
20120034599 SCREENING SYSTEMS UTILIZING RTP801 QUARK PHARMACEUTICALS, INC. 9-Feb-12 Israel
20120040459 REDUCED SIZE SELF-DELIVERING RNAI COMPOUNDS RXi Pharmaceuticals Corporation 16-Feb-12 United States
20120028256 METHOD FOR PROVIDING INFORMATION ON ANTIDEPRESSANT THERAPEUTIC EFFECT USING SINGLE NUCLEOTIDE POLYMORPHISM SAMSUNG LIFE WELFARE FOUNDATION 2-Feb-12 Korea
20120040358 Biomarker Panel for Diagnosis and Prediction of Graft Rejection Sarwal; Minnie M 16-Feb-12 United States
20120045814 Method of Producing Synthetic Petroleum From Coal or Hydrocarbons or From C,H or Oxygen Using a Host Microorganism Shah; Mrugesh 23-Feb-12 United States
20120040406 RATIONALLY-DESIGNED MEGANUCLEASES WITH ALTERED SEQUENCE SPECIFICITY AND DNA-BINDING AFFINITY Smith; James J 16-Feb-12 United States
20120028315 RATIONALLY-DESIGNED MEGANUCLEASES WITH ALTERED SEQUENCE SPECIFICITY AND DNA-BINDING AFFINITY Smith; James J. 2-Feb-12 United States
20120028314 RATIONALLY-DESIGNED MEGANUCLEASES WITH ALTERED SEQUENCE SPECIFICITY AND DNA-BINDING AFFINITY Smith; James J. 2-Feb-12 United States
20120040405 RATIONALLY-DESIGNED MEGANUCLEASES WITH ALTERED SEQUENCE SPECIFICITY AND DNA-BINDING AFFINITY Smith; James J. 16-Feb-12 United States
20120028319 CHLORELLA SPECIES CONTAINING EXOGENOUS GENES Solazyme, Inc. 2-Feb-12 United States
20120045762 LMNA GENE AND ITS INVOLVEMENT IN HUTCHINSON-GILFORD PROGERIA SYNDROME (HGPS) AND ARTERIOSCLEROSIS The Progeria Research Foundation, Inc. 23-Feb-12 Sweden
20120028241 Assay System for Monitoring the Effects of Genetically Engineered Cells to Alter Function of a Synctium The Trustees Of Columbia University In The City Of New York 2-Feb-12 United States
20120034673 Isolated plant deoxyhypusine synthase and nucleotides encoding same Thompson; John E 9-Feb-12 United States
20120034693 RECOMBINANT VECTOR AND USE IN GENE THERAPY Xu; Hongzhan 9-Feb-12 United States
20120045813 GENE ENCODING A PROTEIN HAVING AN ABILITY TO ENHANCE A SELENATE REDUCTION ACTIVITY Yamashita; Mitsuo 23-Feb-12 Japan
20120045801 RECOMBINANT RALSTONIA EUTROPHA CAPABLE OF PRODUCING POLYLACTIC ACID OR POLYLATIC ACID COMPOLYMER, AND METHOD FOR PRODUCING POLYLACTIC ACID OR POLYLATIC ACID COPOLYMER USING SAME Yang; Taek Ho 23-Feb-12 Korea
COMBINATORIAL CHEMISTRY TECHNOLOGY
Appl Number Title Assignee Date Issued Country
20120040842 Gene Expression Markers for Prediction of Patient Response to Chemotherapy Baker; Joffre B 16-Feb-12 United States
20120040871 OLIGONUCLEOTIDE MEDIATED NUCLEIC ACID RECOMBINATION CODEXIS MAYFLOWER HOLDINGS, LLC 16-Feb-12 United States
20120040849 GENE EXPRESSION PROFILE AS AN ENDOMETRIAL RECEPTIVITY MARKER EQUIPO IVI INVESTIGACION SL 16-Feb-12 Spain
20120035079 GENOTOXICITY TESTING GENTRONIX LIMITED 9-Feb-12 United Kingdom
20120035072 KASPP (LRRK2) GENE, ITS PRODUCTION AND USE FOR THE DETECTION AND TREATMENT OF NEURODEGENERATIVE DISORDERS Helmholtz Zentrum Muenchen Deutsches Forschungszentrum fuer Gesundheit und Umwelt 9-Feb-12 Germany
20120040848 MOLECULAR SIGNATURE OF LIVER TUMOR GRADE AND USE TO EVALUATE PROGNOSIS AND THERAPEUTIC REGIMEN INSTITUT PASTEUR 16-Feb-12 France
20120028827 METHOD FOR DETERMINING A RISK, FOR A SUBJECT, OF SUFFERING FROM ATOPIC DERMATITIS OR SEVERITY OF ATOPIC DERMATITIS FOR A SUBJECT SUFFERING FROM ATOPIC DERMATITIS AND METHOD FOR USING A SINGLE-NUCLEOTIDE POLYMORPHISM RS12313273 AS A BIOMARKER FOR DETERMINING THE DEVELOPMENT OR SEVERITY OF ATOPIC DERMATITIS KAOHSIUNG MEDICAL UNIVERSITY 2-Feb-12 Taiwan
20120028819 METHOD FOR THE DETECTION AND CHARACTERIZATION OF A TOXINOGENIC CLOSTRIDIUM DIFFICILE STRAIN KONINKLIJKE PHILIPS ELECTRONICS N.V. 2-Feb-12 Netherlands
20120040863 PROCESS FOR TUMOUR CHARACTERISTIC AND MARKER SET IDENTIFICATION, TUMOUR CLASSIFICATION AND MARKER SETS FOR CANCER National Research Council of Canada 16-Feb-12 Canada
20120046186 Gene Expression Markers for Prediction of Response to Platinum-Based Chemotherapy Drugs PELHAM; ROBERT J. 23-Feb-12 United States
20120028838 Quantification of Gene Expression TRUSTEES OF BOSTON UNIVERSITY 2-Feb-12 United States
DATA PROCESSING
Appl Number Title Assignee Date Issued Country
20120041912 Extracting Gene-Gene Interactions from Gene Expression Data MITRA; Sushmita 16-Feb-12 United States
20120041908 Predictive Radiosensitivity Network Model Torres-Roca; Javier F. 16-Feb-12 United States
20120035855 METHOD OF NETWORK-BASED IDENTIFICATION FOR DRUG ACTION AND/OR SYNERGY EFFECT OF MEDICINE COMBINATION TSINGHUA UNIVERSITY 9-Feb-12 China P. Rep.
DRUG
Appl Number Title Assignee Date Issued Country
20120029056 DIFFERENTIALLY EXPRESSED MICRORNAS AS BIOMARKERS FOR THE DIAGNOSIS AND TREATMENT OF SJOGREN'S SYNDROME Alevizos; Ilias 2-Feb-12 United States
20120027745 ALANINE-GLYOXYLATE AMINOTRANSFERASE THERAPEUTICS Amsterdam Molcular Therapeutics (AMT) IP B.V. 2-Feb-12 Netherlands
20120045475 LIVE ATTENUATED VACCINES AUSTRALIAN POULTRY CRC PTY LIMITED 23-Feb-12 Australia
20120034188 Akt Nucleic Acids, Polypeptides, and Uses Thereof AVENTIS PHARMACEUTICALS INC. 9-Feb-12 United States
20120045394 HUMAN AND MOUSE TARGETING PEPTIDES IDENTIFIED BY PHAGE DISPLA BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM 23-Feb-12 United States
20120035246 SINGLE-STRANDED NUCLEIC ACID MOLECULE HAVING NITROGEN-CONTAINING ALICYCLIC SKELETON BONAC CORPORATION 9-Feb-12 Japan
20120039858 METHODS AND COMPOSITIONS FOR INHIBITING PROPAGATION OF VIRUSES USING RECOMBINANT TETHERIN CONSTRUCTS CHILDRENS HOSPITAL LOS ANGELES 16-Feb-12 United States
20120027737 USE OF PROBIOTICS TO AMELIORATE DIET-INDUCED INSULIN RESISTANCE CHR-HANSEN A/S 2-Feb-12 Denmark
20120046344 TREATMENT OF LIPID TRANSPORT AND METABOLISM GENE RELATED DISEASES BY INHIBITION OF NATURAL ANTISENSE TRANSCRIPT TO A LIPID TRANSPORT AND METABOLISM GENE Collard; Joseph 23-Feb-12 United States
20120041053 DELIVERY OF dsRNA TO ARTHROPODS Commonwealth Scientific and Industrial Research Organisation 16-Feb-12 Australia
20120039889 METHODS OF DIAGNOSING AND TREATING PROSTATE CANCER CHARACTERIZED BY NDRG1-ERG FUSION CORNELL UNIVERSITY 16-Feb-12 United States
20120045452 Mnk KINASE HOMOLOGOUS PROTEINS INVOLVED IN THE REGULATION OF ENERGY HOMEOSTASIS AND ORGANELLE METABOLISM DeveloGen Aktiengesellschaft fuer Entwicklungsbiologische Forschung 23-Feb-12 Germany
20120045451 Mnk KINASE HOMOLOGOUS PROTEINS INVOLVED IN THE REGULATION OF ENERGY HOMEOSTASIS AND ORGANELLE METABOLISM DeveloGen Aktiengesellschaft fuer Entwicklungsbiologische Forschung 23-Feb-12 Germany
20120027727 TARGETED NANOPARTICLES FOR CANCER AND OTHER DISORDERS Epeius Biotechnologies Corporation 2-Feb-12 United States
20120041051 Compositions And Methods For Inhibiting Expression Of MIG-12 Gene Fitzgerald; Kevin 16-Feb-12 United States
20120027725 SAFE LENTIVIRAL VECTORS FOR TARGETED DELIVERY OF MULTIPLE THERAPEUTIC MOLECULES TO TREAT LIVER CANCER Galvin; Jeffrey A. 2-Feb-12 United States
20120041047 Injectable Pharmaceutical Composition for Preventing, Stabilizing and/or Inhibiting Pathological Neovascularization-Related Conditions GENE SIGNAL INTERNATIONAL SA 16-Feb-12 Switzerland
20120039993 Detection of Gene Expression GLAXOSMITHKLINE BIOLOGICALS SA 16-Feb-12 Belgium
20120046233 MUTATIONS IN THE LNK GENE IN PATIENTS WITH MYELOPROLIFERATIVE NEOPLASMS AND OTHER HEMATOLYMPHOID MALIGNANCIES Gotlib; Jason Robert 23-Feb-12 United States
20120046340 Down Regulation of the Gene Expression by Means of Nucleic Acid-Loaded Virus-Like Particles Gruber; Jens 23-Feb-12 Netherlands
20120039812 GENES ASSOCIATED WITH POSTTRAUMATIC-STRESS DISORDER (PTSD) Holsboer; Florian 16-Feb-12 Germany
20120035274 Composition for Prevention or Treatment of Obesity, Dyslipidemia, Fatty Liver or Insulin Resistance Syndrome Comprising Camphene as Active Ingredients Industry-Academic Cooperation Foundation, Yonsei University 9-Feb-12 Korea
20120039913 Selective Histamine H4 Receptor Antagonists for the Treatment of Vestibular Disorders INSERM (institut National de la Sante de la Recher Medicale) 16-Feb-12 France
20120028907 METHODS FOR IDENTIFICATION OF TUMOR PHENOTYPE AND TREATMENT Intelligent Oncotherapeutics, Inc. 2-Feb-12 United States
20120046322 Bioavailable Diacylhydrazine Ligands for Modulating the Expression of Exogenous Genes via an Ecdysone Receptor Complex Intrexon Corporation 23-Feb-12 United States
20120034214 METHODS AND KITS FOR DETERMINING THE PROGNOSIS OF PULMONARY SARCOIDOSIS ISIS Innovation Limited 9-Feb-12 United Kingdom
20120035257 Histone Deacetylase Inhibitors Lan-Hargest; Hsuan-Yin 9-Feb-12 United States
20120045471 RECOMBINANT PARAINFLUENZA VIRUS VACCINE COMPRISING HETEROLOGOUS ANTIGENS DERIVED FROM RESPIRATORY SYNCYTIAL VIRUS MedImmune, LLC 23-Feb-12 United States
20120035247 RNA Interference Mediated Inhibition of Signal Transducer and Activator of Transcription 6 (STAT6) Gene Expression Using Short Interfering Nucleic Acid (siNA) Merck Sharp & Dohme Corp. 9-Feb-12 United States
20120029054 RNA Interference Mediated Inhibition of GATA Binding Protein 3 (GATA3) Gene Expression Using Short Intefering Nucleic Acid (siNA) Merck Sharp & Dohme Corp. 2-Feb-12 United States
20120046364 Novel Sulfonic Acid-Containing Thyromimetics, and Methods for Their Use METABASIS THERAPEUTICS, INC. 23-Feb-12 United States
20120046314 NITROXIDES FOR USE IN TREATING OR PREVENTING NEOPLASTIC DISEASE MITOS, INC. 23-Feb-12 United States
20120027870 Novel Markers for Bladder Cancer Detection MSxHealth SA 2-Feb-12 Belgium
20120027798 ANTIBODY GENE TRANSFER AND RECOMBINANT AAV THEREFOR NATIONWIDE CHILDREN'S HOSPITAL, INC. 2-Feb-12 United States
20120034266 METHODS AND COMPOSITIONS FOR IMPROVING IMMUNE RESPONSE BY A NUTRACEUTICAL ANTIOXIDANT Nel; Andre E. 9-Feb-12 United States
20120028896 USE OF FIBROBLAST GROWTH FACTOR FRAGMENTS NOVARTIS AG 2-Feb-12 Belgium
20120034196 GENE ENCODING A MULTIDRUG RESISTANCE HUMAN P-GLYCOPROTEIN HOMOLOGUE ON CHROMOSOME 7P15-21 AND USES THEREOF (FRANK) The Brigham and Women's Hospital, Inc. 9-Feb-12 United States
20120027792 EXPRESSION VECTORS ABLE TO ELICIT IMPROVED IMMUNE RESPONSE AND METHODS OF USING SAME The Gov of the USA as represented by the Secretary of the Dept. of Health & Human Services N.I.H. 2-Feb-12 United States
20120034318 DIAGNOSTIC METHOD USING PALB2 THE JOHNS HOPKINS UNIVERSITY 9-Feb-12 United States
20120039839 Hypoxia Induced Mitogenic Factor THE JOHNS HOPKINS UNIVERSITY 16-Feb-12 United States
20120029060 Antisense Oligonucleotides for Inducing Exon Skipping and Methods of Use Thereof The University of Western Australia 2-Feb-12 Australia
20120029059 Antisense Oligonucleotides for Inducing Exon Skipping and Methods of Use Thereof The University of Western Australia 2-Feb-12 Australia
20120029058 Antisense Oligonucleotides for Inducing Exon Skipping and Methods of Use Thereof The University of Western Australia 2-Feb-12 Australia
20120029057 Antisense Oligonucleotides for Inducing Exon Skipping and Methods of Use Thereof The University of Western Australia 2-Feb-12 Australia
20120041050 ANTISENSE OLIGONUCLEOTIDES FOR INDUCING EXON SKIPPING AND METHODS OF USE THEREOF The University of Western Australia 16-Feb-12 Australia
20120029061 RNA SEQUENCE-SPECIFIC MEDIATORS OF RNA INTERFERENCE Tuschl; Thomas 2-Feb-12 Germany
20120045421 METHODS FOR THE ISOLATION OF CARDIAC STEM CELLS UNIVERSITA DEGLI STUDI DI ROMA "LA SAPIENZA" 23-Feb-12 Italy
20120040884 Methods and Reagents for Treatment and Diagnosis of Vascular Disorders and Age-Related Macular Degeneration University of Iowa Research Foundation 16-Feb-12 United States
20120046261 COMPOSITIONS AND METHODS FOR DIAGNOSING AND PREVENTING SPONTANEOUS PRETERM BIRTH UNIVERSITY OF UTAH RESEARCH FOUNDATION 23-Feb-12 United States
20120045459 Methods for Treating Autophagy-Related Disorders Van Andel Research Institute 23-Feb-12 United States
20120035215 METHOD OF PREDICTING A PREDISPOSITION TO QT PROLONGATION VANDA PHARMACEUTICALS, INC. 9-Feb-12 United States
20120046339 Novel chorismate mutase gene from the potato cyst nematode globodera rostochiensis Wang; Xiaohong 23-Feb-12 United States
20120028893 Adenovirus 36 E4 ORF 1 Gene and Protein and Their Uses Wayne State University 2-Feb-12 United States
MULTICELLULAR LIVING ORGANISMS
Appl Number Title Assignee Date Issued Country
20120036594 RNA-Mediated Induction of Gene Expression in Plants BASF PLANT SCIENCE COMPANY GMBH 9-Feb-12 Germany
20120036593 Plant Promoter Operable in Endosperm and Uses Thereof BASF Plant Science Company GmbH 9-Feb-12 Germany
20120047602 RNA-Mediated Induction of Gene Expression in Plants BASF Plant Science Company GmbH 23-Feb-12 Germany
20120036595 Whole Seed Specific Promoter BASF PLANT SCIENCE COMPANY GMBH 9-Feb-12 Germany
20120030844 METHODS FOR ALTERING THE REACTIVITY OF PLANT CELL WALLS Bayer BioScience N.V. 2-Feb-12 Belgium
20120030777 METHODS FOR TESTING FOR CALORIC RESTRICTION (CR) MIMETICS Biomarker Pharmaceuticals, Inc. 2-Feb-12 United States
20120030834 METHODS AND COMPOSITIONS FOR ROOT KNOT NEMATODE CONTROL Bradley; John D 2-Feb-12 United States
20120030776 NOVEL GENE DISRUPTIONS, COMPOSITIONS AND METHODS RELATING THERETO Combs; Katherin E. 2-Feb-12 United States
20120030783 RATIONALLY DESIGNED MEGANUCLEASES WITH ALTERED SEQUENCE SPECIFICITY AND DNA-BINDING AFFINITY Duke University 2-Feb-12 United States
20120042401 METHOD FOR INTRODUCING MUTANT GENE, GENE HAVING MUTATION INTRODUCED THEREIN, CASSETTE FOR INTRODUCING MUTATION, VECTOR FOR INTRODUCING MUTATION, AND KNOCK-IN NON-HUMAN MAMMALIAN ANIMAL Hirose; Shinichi 16-Feb-12 Japan
20120030784 BETA-GLUCAN-DEFICIENT GENE IN BARLEY, SYNTHETIC GENE, AND USE OF SAME Incorporated Administration Agency National Agriculture and Food Research Organization 2-Feb-12 Japan
20120036588 METHOD FOR OBSERVING GAD67-POSITIVE CELL IN TRANSGENIC ANIMAL JAPAN SCIENCE AND TECHNOLOGY AGENCY 9-Feb-12 Japan
20120047585 HCO32 AND HCO27 AND RELATED EXAMPLES Medarex, Inc. 23-Feb-12 United States
20120042408 PLANTS PRODUCING 2N GAMETES OR APOMEIOTIC GAMETES Mercier; Raphael 16-Feb-12 France
20120042414 CHIMERIC PROMOTERS AND METHODS OF USE Pioneer Hi-Bred International, Inc. 16-Feb-12 United States
20120047588 Methods for Conditional and Inducible Transgene Expression to Direct the Development of Embryonic, Embryonic Stem, Precursor and Induced Pluripotent Stem Cells THE CURATORS OF THE UNIVERSITY OF MISSOURI 23-Feb-12 United States
20120030782 Compositions and Methods for Generating Transgenic Animals The Regents of The University of Michigan 2-Feb-12 United States
NATURAL RESINS OR DERIVATIVES
Appl Number Title Assignee Date Issued Country
20120029174 METHODS FOR PRODUCING SUBSTANTIALLY HOMOGENEOUS HYBRID OR COMPLEX N-GLYCANS IN METHYLOTROPHIC YEASTS VIB, VZW 2-Feb-12 Azerbaijan
ORGANIC COMPOUNDS
Appl Number Title Assignee Date Issued Country
20120041184 RNA INTERFERENCE MEDIATED INHIBITION OF HUMAN IMMUNODEFICIENCY VIRUS (HIV) GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA) Beigelman; Leonid 16-Feb-12 United States
PLANT PROTECTING AND REGULATING COMPOSITIONS
Appl Number Title Assignee Date Issued Country
20120040828 METHOD TO IMPROVE PHOSPHATE SOLUBILIZATION IN PLANTS CONSIGLIO NAZIONALE DELLE RICERCHE 16-Feb-12 Italy
Bookmark and Share

Login



alta vista babel fish
To traslate this page, click a flag!
flag flag flag flag flag flag flag flag

Advertisements

Miracle Ear
What will your miracle sound like?
Miracle Ear Hearing Aids
Dayal Resources, Inc.
Translations from German to English, including patents, research papers, legalese and materials for publication. Dayal Resources, Inc. is your dependable resource. Please contact wdayal@dayalresources.com
Eden's Bounty Multi-SanTM
Colorless, odorless, biodegradable instant sanitizer is effective against both gram positive and gram-negative bacteria; kills in 30 seconds. Free of chlorine and quaternary ammonium compounds. EPA registered food contact surface sanitizer. Austin Davis Industries, Inc.
TERRA+ CLEAN Acid-Replacement Surface Cleaner
Safe, totally natural, 100% biodegradable, multi-functional cleaning product providing safety in the workplace for both humans and environmental surfaces - without compromising performance. Can be diluted up to 25:1. Austin Davis Industries, Inc.